BridgeMD
Tests treatment safety and results for Dengue
Official title Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients
ClinicalTrials.gov ID: NCT06747130
What this study is testing
What is Montelukast?
Montelukast is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for dengue.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn if drug montelukast works to treat dengue in adults. It will also learn about the safety of drug montelukast .
- Phase 3: a large, late-stage study
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Patient age \>18 years
- Dengue infection diagnosed by NS1 antigen, or polymerase chain reaction
- Admitted to the hospital
- Written informed consent from patient or attending relative able to and willing to give informed consent
You likely can't join if
- Other possible cause of fever other than dengue infection
- Pregnancy
- Unable to take medication
- Aminotransferase level above 150 U/l
- Allergy to paracetamol or tramadol
- Paracetamol indicated for condition other than dengue infection
See the full eligibility criteria
- Patient age \>18 years
- Dengue infection diagnosed by NS1 antigen, or polymerase chain reaction
- Admitted to the hospital
- Written informed consent from patient or attending relative able to and willing to give informed consent
- Other possible cause of fever other than dengue infection
- Pregnancy
- Unable to take medication
- Aminotransferase level above 150 U/l
- Allergy to paracetamol or tramadol
- Paracetamol indicated for condition other than dengue infection
- Critically ill patient who need ICU or invasive ventilation support
- History of cirrhosis
- Unable to communicate
- Other indication of montelukast
- History of psychiatric illness
The study team makes the final eligibility decision.
Where it's taking place
- Bangkok, Thailand
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Bangkok, Thailand. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.